Skip to content

Clinical trials

Phase 1 Cognition Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognition Disorders Phase: Phase 1 Country / region: United States Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20111
20161
20171
20201
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alzheimer's Disease Expert Lab (ADEL), Inc.1
NXTech1
National Institute of Mental Health (NIMH)1
Siena Biotech S.p.A.1
University of California, San Diego1
University of Maryland, Baltimore1
University of Rochester1
University of Southern California1
Yale University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognition Disorders9
Cognitive Dysfunction4
Mental Disorders3
Acquired Immunodeficiency Syndrome2
Brain Diseases2
Central Nervous System Diseases2
Dementia2
HIV Infections2
Nervous System Diseases2
Neurocognitive Disorders2

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.